New Zealand’s Izon Science will unveil its latest breakthrough in nanoparticle analysis in the US this week, introducing its latest nano particle measurement system.
The Variable Pressure Module (VPM) adds to Izon Science’s existing qNano and qViro instrument range to provide the world’s most comprehensive nanoparticle analysis system.
The launch will be held on 4 May at the New Zealand Pavilion at the 2010 BIO International Convention in Chicago. A delegation of 25 innovative New Zealand companies and research organisations are attending the event, the largest biotechnology event worldwide.
“Our new platform delivers a quantum leap in capability for our research customers. Users can use simple default analyses or process the stream of data to suit their own requirements to gain detailed information about particles,” Hans van der Voorn, the executive chairman of Izon says in a press release.
Researchers using Izon’s nanoparticle analysis system can measure and characterise virtually all particles including nanoparticles, viruses, bacteria and bioparticles such as exosomes and liposomes.
“We are constantly finding new applications for our technology, largely driven by the measurement needs of our collaborators and customers around the world,” says Van der Voorn.
Izon’s invention of the Variable Pressure Module (VPM) provides precise control of liquid flow in addition to the standard electrophoretic operation of nanopores.
The VPM designed by Izon helps nano-sized particles (in both biological and synthetic particle) to be measured quickly and easily. The extended concentration range enabled by the VPM allows measurement of sample concentrations down to a level that it expects will become a globally adopted standard for particle concentration measurement.
Its equipments are now used in projects including virus quantitation and analysis, oncolytic viruses, marine science, drug delivery systems, nanoparticle charge measurement, diagnostic applications using antibodies and nanoparticles, bioparticle analysis, and controlled dispensing of particles and biomolecules by count.
Izon’s qNano and qViro technology has been sold to research organisations around the world. Collaboration partners in the US include Massachusetts Institute of Technology (MIT), Johns Hopkins University, National Institute of Standards and Technology (NIST), and University of California Santa Cruz.
The New Zealand delegation at the BIO International Convention in Chicago is led by NZBIO and supported by New Zealand Trade & Enterprise. Around 13,000 executives, investors, scientists, researchers, policy makers and journalists from around the world are expected to the event, May 3-6, 2010.
Izon website: http://www.izon.com/
